Literature DB >> 18430105

The prognostic impact of occult lymph node metastasis in cancer of the esophagus or esophago-gastric junction: systematic review and meta-analysis.

M J McGuill1, P Byrne, N Ravi, J Reynolds.   

Abstract

Attempts to define the clinical significance of occult lymph node metastasis have yielded mixed results. We set out to quantify the influence on disease-free survival of occult lymph node metastasis in cases of esophageal or gastro-esophageal cancer previously staged as lymph node-negative by conventional H&E staining. We performed a systematic review and meta-analysis of observational studies published between 1966 and 2006 (identified through Medline and Embase). Twelve suitable cohort studies were identified. These studies suggest there is a significant (P < 0.001) association between occult lymph node metastasis and prognosis in cancer of the esophagus or esophago-gastric junction (pooled hazard ratio 3.16 with 95% confidence intervals of 2.25-4.42). We did not demonstrate study quality, number of nodes examined or number of lymph node sections examined to be significant sources of intertrial heterogeneity. Data from observational studies suggest that occult lymph node metastasis is an important prognostic factor in cancer of the esophagus or gastro-esophagus. Meta-analysis using individual patient data can now be justified.

Entities:  

Mesh:

Year:  2008        PMID: 18430105     DOI: 10.1111/j.1442-2050.2007.00765.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  Sentinel lymph node biopsy in esophageal cancer: should it be standard of care?

Authors:  Sarah K Thompson; Dylan Bartholomeusz; Glyn G Jamieson
Journal:  J Gastrointest Surg       Date:  2011-08-02       Impact factor: 3.452

2.  Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study.

Authors:  Yutaka Miyawaki; Hiroshi Sato; Naoto Fujiwara; Shuichiro Oya; Hirofumi Sugita; Yasumitsu Hirano; Tomohiko Yamane; Shinichi Sakuramoto; Kojun Okamoto; Shigeki Yamaguchi; Isamu Koyama
Journal:  Int J Clin Oncol       Date:  2019-12-23       Impact factor: 3.402

Review 3.  Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View.

Authors:  Jin Woong Cho; Suck Chei Choi; Jae Young Jang; Sung Kwan Shin; Kee Don Choi; Jun Haeng Lee; Sang Gyun Kim; Jae Kyu Sung; Seong Woo Jeon; Il Ju Choi; Gwang Ha Kim; Sam Ryong Jee; Wan Sik Lee; Hwoon-Yong Jung
Journal:  Clin Endosc       Date:  2014-11-30

4.  Evaluation of metastatic lymph nodes in cN0 thoracic esophageal cancer patients with inconsistent pathological lymph node diagnosis.

Authors:  Akiyuki Wakita; Satoru Motoyama; Yusuke Sato; Yuta Kawakita; Yushi Nagaki; Kaori Terata; Kazuhiro Imai; Yoshihiro Minamiya
Journal:  World J Surg Oncol       Date:  2020-05-29       Impact factor: 2.754

5.  Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma.

Authors:  Zhaoyang Yan; Xinjian Xu; Juntao Lu; Yang You; Jinsheng Xu; Tongxin Xu
Journal:  BMC Gastroenterol       Date:  2022-04-03       Impact factor: 3.067

6.  A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer.

Authors:  Huiru Dai; Minling Liu; Xueying Li; Tingwei Li; Wensheng Huang; Jiehao Liao; Yun Li; Shuo Fang
Journal:  World J Surg Oncol       Date:  2022-08-26       Impact factor: 3.253

7.  Combined CT texture analysis and nodal axial ratio for detection of nodal metastasis in esophageal cancer.

Authors:  Han Na Lee; Jung Im Kim; So Youn Shin; Dae Hyun Kim; Chanwoo Kim; Il Ki Hong
Journal:  Br J Radiol       Date:  2020-04-15       Impact factor: 3.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.